| Literature DB >> 32587272 |
Chih-Hsiu Cheng1, Dar-Ming Lai2, Phooi Yee Lau3, Shwu-Fen Wang3,4, Andy Chien5, Jaw-Lin Wang6, Wei-Li Hsu7,8.
Abstract
Patients with cervical myelopathy may manifest impairments in functional activities and balance control caused by compression of the spinal cord. The objective of the current study was to determine long-term changes in the upright balance control of patients with cervical myelopathy who had undergone cervical decompression surgery. This is a prospective cohort study from the preoperative phase to 3 months, 6 months, and 1 year postsurgery. Fifty-three patients with cervical myelopathy were recruited for the cervical myelopathy group and 22 age-matched healthy controls were recruited for the control group. Functional assessments including Japanese Orthopedic Association Cervical Myelopathy Evaluation Questionnaire-Lower Extremity Function (JOACMEQ-LEF) and 10-second step test; as well as balance assessments including postural sway (center-of-pressure: COP) were performed for both groups. The JOACMEQ-LEF (p = 0.036) scores of the myelopathy group improved postoperatively, and a significant decrease in COP variables of postural sway was observed. The upright posture was less stable in the myelopathy group than in the control group (p < 0.05) both before and after surgery. The effect size and standard response mean of the COP variables ranged from -0.49 to 0.03 at 3 months, 6 months, and 1 year postsurgery. The upright balance control had improved significantly 6 months after decompression surgery. However, the balance control of the patients who had undergone decompression surgery remained less stable than that of the age-matched healthy controls. Balance training should be initiated before 6 months postsurgery to accelerate balance control recovery in patients with cervical myelopathy.Entities:
Mesh:
Year: 2020 PMID: 32587272 PMCID: PMC7316780 DOI: 10.1038/s41598-020-66057-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flowchart of the study procedure.
Descriptive characteristic of myelopathy group with surgery and healthy age-matched control group.
| Myelopathy Group | Age-matched Control Group | p value | |
|---|---|---|---|
| Subject Number (Male: Female) | 53 (40:13) | 22 (6:16) | — |
| Age (years) | 55.50 ± 9.63 | 56.41 ± 9.66 | 0.861 |
| Height (m) | 1.65 ± 0.08 | 1.62 ± 0.07 | 0.087 |
| Weight (kg) | 68.73 ± 11.28 | 63.32 ± 9.90 | 0.054 |
| BMI (kg/m2) | 25.19 ± 3.33 | 24.24 ± 3.32 | 0.268 |
| ACDF | 24 | NA | |
| Laminoplasty | 15 | NA | |
| Arthroplasty | 1 | NA | |
| ACDF + Arthroplasty | 12 | NA | |
| Other | 1 | NA | |
BMI: body mass index; ACDF: anterior cervical discectomy and fusion; NA: not available.
Figure 2Comparison of Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire-lower extremities function (JOACMEQ-LEF) and 10 second step test after 3 months, 6 months and 1 year of surgery (preoperative phase as baseline). 0 M: preoperative phase; 3 M: postoperative 3 months; 6 M: postoperative 6 months; 1Y: postoperative 1 year. *Significant difference between 0 M and 1Y (p < 0.05/6 after Bonferroni’s adjustment). #Significant difference between 3 M and 1Y (p < 0.05/6 after Bonferroni’s adjustment).
Figure 3Comparison between phases and groups in COP variables during eyes-open stance in (A) 95% confidence ellipse area, (B) mean velocity, (C) range-AP, (D) range-ML, (E) RMS distance-AP and (F) RMS distance-ML. 0 M: myelopathy group at preoperative phase; 3 M: myelopathy group at postoperative 3 months; 6 M: myelopathy group at postoperative 6 months; 1Y: myelopathy group at postoperative 1 year; Control: age-matched control group. *Significant difference between phases of surgery (p < 0.05). §Significant difference between myelopathy group and age-matched control group (p < 0.05).
Figure 4Comparison between phases and groups in COP variables during eyes-closed stance in (A) 95% confidence ellipse area, (B) mean velocity, (C) range-AP, (D) range-ML, (E) RMS distance-AP and (F) RMS distance-ML. 0 M: myelopathy group at preoperative phase; 3 M: myelopathy group at postoperative 3 months; 6 M: myelopathy group at postoperative 6 months; 1Y: myelopathy group at postoperative 1 year; Control: age-matched control group. *Significant difference between phases of surgery (p < 0.05). §Significant difference between myelopathy group and age-matched control group (p < 0.05).